Navigation Links
Atrium generates strong growth during the second quarter
Date:8/7/2008

six-month period ended June 30, 2008, revenues from continuing operations were $140.3 million, up 119% from $64.1 million for the corresponding period in 2007. EBITDA from continuing operations for the first half of 2008 was $36.6 million, an increase of 108% compared to $17.6 million for the same period last year. For the first half of 2008, total net earnings increased by 284% to $58.6 million generating fully diluted earnings per share of $1.77, compared to $15.2 million and $0.47 per share for the first six months of 2007.

"We are extremely satisfied with our results for the second quarter, confirming the soundness of our strategic development plan. Strong organic growth exceeding our target, combined with the benefits of our recent acquisitions, allows us to be optimistic for the remainder of 2008. Moreover, completing the sale of our Active Ingredients and Specialty Chemicals Division is providing us all the financial flexibility required to pursue our growth strategy through acquisitions in the promising sector of specialties health and nutrition products," said Mr. Pierre Fitzgibbon, Atrium's President and Chief Executive Officer.

For the second quarter of 2008, cash flows from continuing operating activities, before changes in non-cash working capital items, were $12.2 million, an increase of 149% compared to $4.9 million for the same period of the preceding year. For the six-month period ended June 30, 2008, cash flows from continuing operating activities, before changes in non-cash working capital items, were $23.9 million, an increase of 115% compared to $11.1 million for the same period in 2007. As at June 30, 2008, the Company had a total debt amounting to $144 million as the Company has a revolving credit facility that provides $300 million of borrowing capacity. In addition, through an unsecured loan, the Company has additional capacity of $35.9 million that can be used in whole or in part by December 31, 2008 according to the amendment
'/>"/>

SOURCE Atrium Innovations Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Atrium Innovations Announces Management Changes
2. Atrium Innovations to Hold 2007 Third Quarter Financial Results Conference Call and Webcast on November 8
3. Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007
4. Atrium Innovations to Hold 2007 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast on February 29
5. Atrium Innovations to Hold 2008 First Quarter Financial Results Conference Call and Webcast on May 6
6. Atrium shows a strong financial performance for its first quarter
7. Atrium Medical Receives FDA Approval for its Novel C-QUR Lite(TM) V-Patch and C-QUR Edge(TM) V-Patch
8. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
9. Atrium Innovations to Present at Upcoming 28th Annual Canaccord Adams Global Growth Conference
10. Reovirus Infection of Melanoma Cells Generates Anti-Tumour Immunity
11. Imaging Diagnostic Systems Generates Cash From Building Sale
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Scientists at USC have developed a new microscopy ... in living animals at higher-than-ever resolution. , Dubbed ... allows imaging resolutions that are an order of ... insights into the behavior of biomolecules at the ... Sept. 18 by Nature Communications , the ...
(Date:9/18/2014)... Silicon-valley Electronic Data Capture (EDC) provider ... , the latest addition to Clinovo’s CRO Partnership Program. ... (CRO) Program, Clinovo further expands its global reach to ... training, we are now able to build studies on ... can also rely on Clinovo to fully support the ...
(Date:9/18/2014)... New York, NY (PRWEB) September 18, 2014 ... has completed negotiations with Salem Realty Group and has ... and development space within the Salem Executive Complex adjacent ... cutting ceremony was held on Friday September 5th. Whitehouse ... to refit the entire space specifically for package testing. ...
(Date:9/17/2014)... Sept. 17, 2014 The global consumption of squalene ... Squalene is a natural skin-identical chemical that finds applications in ... food supplements, pharmaceuticals, and in other applications like high grade ... has a few major players and is regionally segregated. Sophim ... Liver Oil Co. Ltd. ( Japan ), SeaDragon ...
Breaking Biology Technology:Scientists pioneer microscopy technique that yields fresh data on muscular dystrophy 2Digitaliza TXT Joins Clinovo’s CRO Partnership Program, Bringing Its Open Source EDC System, ClinCapture to Latin America 2Digitaliza TXT Joins Clinovo’s CRO Partnership Program, Bringing Its Open Source EDC System, ClinCapture to Latin America 3Whitehouse Labs Announces Package Testing Laboratory Expansion 2Whitehouse Labs Announces Package Testing Laboratory Expansion 3Whitehouse Labs Announces Package Testing Laboratory Expansion 4Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 2Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 3
... Third Quarter Highlights Recognized ... from Department of Defense (DoD) for nerve agent medical countermeasure ... profit split on worldwide sales of ST-246 and related products ... Completed 1500L commercial scale-up and first cGMP manufacturing run ...
... 8, 2011 Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... today announced financial results for the third quarter of 2011. ... a net loss of $4.6 million, or $0.10 per share, ... $0.31 per share, for the third quarter of 2010. As ...
... for data-intensive biomedical and genetic research -- is ... team of researchers including Anton Nekrutenko, an associate ... State University; Kateryna Makova, an associate professor of ... Emory University, developed the new technology, which will ...
Cached Biology Technology:PharmAthene Reports Third Quarter 2011 Financial and Operating Results 2PharmAthene Reports Third Quarter 2011 Financial and Operating Results 3PharmAthene Reports Third Quarter 2011 Financial and Operating Results 4PharmAthene Reports Third Quarter 2011 Financial and Operating Results 5PharmAthene Reports Third Quarter 2011 Financial and Operating Results 6PharmAthene Reports Third Quarter 2011 Financial and Operating Results 7PharmAthene Reports Third Quarter 2011 Financial and Operating Results 8Orexigen® Therapeutics Reports Third Quarter Financial Results 2Orexigen® Therapeutics Reports Third Quarter Financial Results 3Orexigen® Therapeutics Reports Third Quarter Financial Results 4Orexigen® Therapeutics Reports Third Quarter Financial Results 5Galaxy DNA-analysis software is now available 'in the cloud' 2Galaxy DNA-analysis software is now available 'in the cloud' 3
(Date:9/17/2014)... Informatics at IMIM (Hospital del Mar Medical Research Institute) ... recently published a study in eLife showing ... in the evolution of new proteins, some of which ... Ribosomes produce proteins from the instructions found in an ... is RNA containing information for the synthesis of proteins, ...
(Date:9/17/2014)... Mich. Mutations in the human retinoblastoma protein gene ... State University scientists have turned to fruit fly eyes ... , In a paper featured on the cover ... Biological Chemistry , Michigan State University researchers provide the ... to those present in the human cancer gene, said ...
(Date:9/17/2014)... decades of decline, grasses have returned to some once-denuded ... marsh in those places seems healthy again, but a ... the marsh coastal protection remains diminished. , ... hasn,t come back," said ecologist Mark Bertness, professor of ... in the journal Biological Conservation . "The metric ...
Breaking Biology News(10 mins):Parts of genome without a known function may play a key role in the birth of new proteins 2Abnormal properties of cancer protein revealed in fly eyes 2Cape Cod saltmarsh recovery looks good, falls short 2Cape Cod saltmarsh recovery looks good, falls short 3
... In order for a gene to create a protein, ... as messenger RNA. These RNA molecules are the instruction manuals ... how to build a protein. A few years ago, scientists ... metabolic products (metabolites) can bind to. In doing so, they ...
... New drugs that are helping fight a multi-front war on ... of Georgia researchers said. Cancer and cardiovascular disease, both ... shock protein 90 inhibitors as a treatment could become additional ... Biology Center. "I think hsp90 inhibitors may be some ...
... David L. Rimoin, MD, PhD, FACMG of Cedars-Sinai ... College of Medical Genetics Foundation (ACMGF) second annual Lifetime ... Dr. Rimoin was recognized for his decades of contributions ... and heritable disorders of connective tissue, and for helping ...
Cached Biology News:Genes under control 2New cancer therapy may fight cardiovascular disease 2Leader in genetics, Dr. David L. Rimoin, receives ACMG Foundation Lifetime Achievement Award 2Leader in genetics, Dr. David L. Rimoin, receives ACMG Foundation Lifetime Achievement Award 3
... The TUNEL-based assay kit provides complete ... cells for convenient detection of DNA ... sections. The incorporation of BrdU in ... biotinylated or digoxigenylated methods. Results can ...
... ergonomic microscopes are now available in digital ... DM-BA200 comes packed with Motic's patented Colour ... plug and play digital image capture head. ... a reversed quadruple nosepiece, deliver high quality ...
... The Fujifilm Life Science LAS-3000 ... technology with a simplified user interface, ... a wide range of modularities. The ... applications, and the perfect standard system ...
This kit is designed to select cells labeled with biotinylated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
Biology Products: